Home
Conditions
Neuroendocrine Tumor

Clinical trial condition

Neuroendocrine Tumor

Explore clinical trials studying Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.

30 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumor trial results

Completed

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

NCT01099540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Samsung Cancer Center Seoul, South Korea

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00131911

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

NCT00942682

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +18 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

NCT00363051

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +18 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

USC Medical Center Los Angeles, California, United States

Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. Los Angeles, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 54 locations

View Trial Details

Completed

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

NCT00434109

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

NCT00789841

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms, +7 more
Locations: Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A Aarhus, Denmark

View Trial Details

Completed

Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

NCT00165230

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconness Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations: Katmai Oncology Group Anchorage, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 433 locations

View Trial Details

Active, Not Recruiting

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

NCT00569127

Conditions: Colorectal Neuroendocrine Tumor G1, Gastric Neuroendocrine Tumor G1, Neoplasms, +8 more
Locations: Providence Hospital Mobile, Alabama, United States

Fairbanks Memorial Hospital Fairbanks, Alaska, United States

Mercy Hospital Fort Smith Fort Smith, Arkansas, United States

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

View all 494 locations

View Trial Details

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT02628067

Conditions: Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
Locations: Not specified

View Trial Details

Neuroendocrine Tumor

Neuroendocrine Tumor trial results

Related conditions